MTB@ZPM
Molecular Tumor Board at the Center for Personalized Medicine Tübingen
Rekrutierend
NCT-Nummer:
NCT03503149
Studienbeginn:
März 2018
Letztes Update:
19.04.2018
Wirkstoff:
-
Geschlecht:
Alle
Altersgruppe:
Alle
Phase:
-
Sponsor:
University Hospital Tuebingen
Collaborator:
-
Studienleiter
Ghazaleh Tabatabai, Prof
Principal Investigator
University Hospital Tübingen
Kontakt
Ghazaleh Tabatabai, Prof
Kontakt:
Phone: 0049707129
Phone (ext.): 83269
E-Mail: ghazaleh.tabatabai@med.uni-tuebingen.de» Kontaktdaten anzeigen
Nisar P Malek, Prof
Kontakt:
Phone: 0049707129
Phone (ext.): 83269
E-Mail: ghazaleh.tabatabai@med.uni-tuebingen.de» Kontaktdaten anzeigen
Detailed Description:
Molecular Tumor Board at the Center for Personalized Medicine The study objectives are
- To ensure a prospective documentation of all patients who are referred to the Molecular
Tumor Board in routine clinical care
- To prospectively ensure the documentation of MTB patients with an emphasis to clinical
outcome parameters progression-free survival (PFS), overall survival (OS) and further
response assessments (e.g. peripheral immunmonitoring, imaging parameters)
- To prospectively assess patient-reported outcome of MTB patients
- To evaluate compliance to MTB suggestions in routine clinical care
Inclusion Criteria:
- Given informed consent ("broad consent" of the University Hospital Tübingen)
- ≥ 18 years of age
- Clinical indication for a referral to Molecular Tumor Board by the treating physician
Exclusion Criteria:
- The MTB assists the referring physician with the interpretation and the use of tumor
molecular profiling data for deciding on a therapeutic strategy. Therefore, this board
is confined to cancer patients and cannot provide any service for non-cancer patients
Primary outcome:
1. Progression-free survival (Time Frame - 6 months):
Progression-free survival
Secondary outcome:
1. Overall survival (Time Frame - an average of 1 year):
Progression-free survival
- no intervention:
observational study
Quelle: ClinicalTrials.gov
Sie können folgenden Inhalt einem Kollegen empfehlen:
"Molecular Tumor Board at the Center for Personalized Medicine Tübingen"
Bitte tragen Sie auch die Absenderdaten vollständig ein, damit Sie der Empfänger erkennen kann.
Die mit (*) gekennzeichneten Angaben müssen eingetragen werden!
